Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading

By William White, InvestorPlace Writer
Kenvue (KVUE) stock is set to start trading on Thursday as the company completes its spinoff from Johnson & Johnson (JNJ).

Why Is Altamira Therapeutics (CYTO) Stock Up 45% Today?

By William White, InvestorPlace Writer
Altamira Therapeutics (CYTO) stock is taking off on Thursday despite a lack of news from the RNA-based therapeutics company.

7 Stock Upgrades and Downgrades Alerts You Cannot Ignore

By Chris Lau, InvestorPlace Contributor
Analyst stock upgrades and downgrades caught the market's attention in the last week and putting investors on notice for buys and sells.

7 A-Rated Stocks to Buy for May 2023

By Louis Navellier and the InvestorPlace Research Staff
This is no time to "sell in May and go away." You'll never get the power of compounding interest that way. Find some stocks to buy instead.

KVUE Stock: Should You Buy Into the Kenvue IPO?

By Dana Blankenhorn, InvestorPlace Contributor
KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business.

Why Is Akili (AKLI) Stock Up 21% Today?

By William White, InvestorPlace Writer
Akili (AKLI) stock is gaining on Wednesday after the company's video game treatment showed success in reducing ADHD in adults.

Why Is ImmunoGen (IMGN) Stock Up 125% Today?

By William White, InvestorPlace Writer
ImmunoGen (IMGN) stock is rising higher on Wednesday after the company released results from a Phase 3 trial for treating ovarian cancer.

LLY Stock Alert: Eli Lilly Announces Positive Alzheimer’s Drug Data

By William White, InvestorPlace Writer
Eli Lilly (LLY) stock is getting a boost on Wednesday after the company announced results from an Alzheimer's clinical trial.

Why Is Akanda (AKAN) Stock Up 114% Today?

By William White, InvestorPlace Writer
Akanda (AKAN) stock is on the rise Wednesday after the cannabis company released its annual report after saying it would be late.

Why Is Aptorum (APM) Stock Up 166% Today?

By William White, InvestorPlace Writer
Aptorum (APM) stock is climbing higher on Wednesday despite a lack of news from the clinical-stage biopharmaceutical company.

7 Stocks Poised for a Major Breakout in May 2023

By Muslim Farooque, InvestorPlace Contributor
These best breakout stocks are set for an impressive rebound ahead as the stock market starts picking up the pace again

7 Best Cathie Wood Stocks for Your May 2023 Buy List

By Alex Sirois, InvestorPlace Contributor
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent.

3 Dividend Stocks to Buy for 100% Total Returns in One Year

By Faisal Humayun, InvestorPlace Contributor
These are the blue-chip dividend stocks to buy for high total returns in the next one year.

The 3 Most Talked-About Stocks and Cryptos Right Now

By Faizan Farooque, InvestorPlace Contributor
Looking for the latest investment opportunities? Keep an eye on these three trending, hot, and popular stocks and cryptos.

KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?

By Samuel O'Brient, InvestorPlace Reporter
Johnson & Johnson spinoff Kenvue is gearing up to go public on May 4. Here's what investors need to know about KVUE stock and the Kenvue IPO.

3 Stocks to Buy on the Cusp of a Breakout

By Joel Baglole, InvestorPlace Contributor
Here are three stocks to buy, for investors looking for companies on the cusp of a potential breakout driven by secular growth catalysts.

3 High-Growth Penny Stocks to Consider Buying in April 2023

By Chris MacDonald, InvestorPlace Contributor
Here are three high-growth penny stocks long-term investors may want to keep on their watch list, or buy, in April.

3 Megatrend Stocks to Buy for 10x Potential Returns

By Alex Sirois, InvestorPlace Contributor
These megatrend stocks benefit from tailwinds provided by secular catalysts, but are also strong companies in their own right.

The 3 Most Promising Gene Editing Stocks to Buy in 2023

By John Blankenhorn, InvestorPlace Contributor
Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in.
Load More Articles